BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lin TC, Chiu YC, Chiu HC, Liu WC, Cheng PN, Chen CY, Chang TT, Wu IC. Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy. World J Gastroenterol 2018; 24(6): 725-736 [PMID: 29456411 DOI: 10.3748/wjg.v24.i6.725]
URL: https://www.wjgnet.com/1007-9327/full/v24/i6/725.htm
Number Citing Articles
1
I-Chin Wu, Wen-Chun Liu, Yen-Cheng Chiu, Hung-Chih Chiu, Pin-Nan Cheng, Ting-Tsung Chang. Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg LossMicroorganisms 2021; 9(6): 1146 doi: 10.3390/microorganisms9061146
2
Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir TherapyJournal of Clinical Medicine 2019; 8(11): 1892 doi: 10.3390/jcm8111892
3
Meng-Lan Wang, Rong Deng, En-Qiang Chen, Chuan-Min Tao, Juan Liao, Tao-You Zhou, Juan Wang, Hong Tang. Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapyClinics and Research in Hepatology and Gastroenterology 2019; 43(3): 301 doi: 10.1016/j.clinre.2018.10.020
4
Zhidan Zheng, Wei Liao, Lili Liu, Shaohang Cai, Haipeng Zhu, Sichun Yin. Effect of nucleos(t)ide analogue on serum HBsAg level in chronic hepatitis B patients: A 3-years studyBiomedicine & Pharmacotherapy 2020; 122: 109698 doi: 10.1016/j.biopha.2019.109698
5
Gian Paolo Caviglia, Yulia Troshina, Enrico Garro, Marcantonio Gesualdo, Serena Aneli, Giovanni Birolo, Fabrizia Pittaluga, Rossana Cavallo, Giorgio Maria Saracco, Alessia Ciancio. Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World StudyJournal of Clinical Medicine 2021; 10(15): 3308 doi: 10.3390/jcm10153308